“Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia.
“The findings could also inform the development of a prognostic test for patients with other forms of cancer.
“Researchers from the School of Medicine used pioneering techniques for measuring the length and function of tiny structures known as ‘telomeres’ – repeating sections of DNA found at the ends of chromosomes.
“They used these techniques to determine if the telomeres were working or not in cells from patients with chronic lymphocytic leukaemia (CLL). Patients with short dysfunctional telomeres displayed a considerably poorer clinical outcome compared to those with long and functional telomeres.”